Australia's most trusted
source of pharma news
Thursday, 19 September 2024
Posted 29 February 2024 AM
The industry spent more than $12 million in payments to healthcare professionals over six months last year with Novartis, Pfizer and AstraZeneca forking out the most.
A Pharma in Focus analysis of Medicines Australia's transparency reporting data on Payments to Healthcare Professionals between May 2023 to October 2023 shows Novartis was by far the biggest spender over the reporting period.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.